News and blogs
24 results found.
Blood cancer survivor is ‘luckiest man alive’ as treatment helps gain approval for use on NHS
England’s drug regulators have recommended two new treatments for blood cancer for use on the NHS.
20th Feb 2025

Our highlights from the 2024 ASH conference
Read more on highlights from the 2024 annual American Society of Haematology (ASH) conference
31st Jan 2025

New blood cancer drugs in Scotland approved
Regulators in Scotland, has approved two new blood cancer treatments for use on the NHS in Scotland. A CAR-T therapy for diffuse large B-cell lymphoma is one of the treatments.
11th Nov 2024

World Cancer Research Day: our new research projects
We are funding eight new research projects we are funding taking our total number of research projects to 87 across the UK.
24th Sep 2024

CAR-T therapy Kymriah available for a form of childhood and young-adult leukaemia on the NHS
'Life-changing' blood cancer drug, Kymriah is now available routinely on the NHS for childhood and young-adult B-cell acute lymphoblastic leukaemia on the NHS
11th Apr 2024

How a Yorkshire house led to five pioneering research projects
Last year you raised an incredible £1.95m for Blood Cancer UK in the Omaze Millon Pound House Draw. Find out more about the incredible research projects this is helping to support.
11th Apr 2024

Simon Thomas launches new blood cancer projects
Blood Cancer UK reveals that the money from their latest partnership with Omaze UK is their largest single donation to date. The money has now been invested into research via the Omaze x Blood Cancer UK Research Fund.
19th Mar 2024

Scotland drug regulators rule blood cancer isn't cost effective
Yescarta, the blood cancer drug is not to be made available on the NHS in Scotland even though it is in England. Blood Cancer UK says it highlights the inequality in access to blood cancer drugs across the UK.
12th Mar 2024

From despair to hope: The Matthew Wilson Multiple Myeloma Fund
Matthew Wilson establishes the Matthew Wilson Multiple Myeloma Fund (MWMMF) at Blood Cancer UK.
26th Jan 2024

Blood Cancer UK fund new research
Blood Cancer UK are funding 16 new research projects worth £14 million
22nd Mar 2023

CAR-T cell therapy made available on NHS
Yescarta has now been made available for people with certain types of lymphoma on the NHS in England
26th Jan 2023

EHA annual conference 2020: the promising future of blood cancer research
Blood Cancer UK rounds up the exciting breakthroughs in blood cancer research discussed at this year’s European Haematology Association conference.
24th Jun 2020

Researchers say blood cancer beaten in a few decades
Blood cancer researchers are excited about the future and say the scientific progress made mean blood cancer can be beaten in the next few decades.
2nd Feb 2020

The American Society of Haematology (ASH) Annual Meeting saw 30,000 experts to discuss new research examining blood cancers and other blood disorders.
The American Society of Haematology (ASH) Annual Meeting saw 30,000 experts to discuss new research examining blood cancers and other blood disorders.
2nd Feb 2020

Meet the Scientists 2019 - highlights
The event showcases recent breakthroughs in blood cancer research. It's an opportunity to hear about the latest updates in treatments and technologies.
10th Dec 2019

Blood cancer documentary gave me hope.
War in the Blood, a new BBC documentary follows two people who received CAR-T therapy, a groundbreaking new treatment for blood cancer, as part of a clinical trial. Kate, our Senior Support Services Manager, reviews the documentary.
8th Jul 2019

CAR-T access in Scotland for childhood leukaemia
Children and young people in Scotland with ALL who relapse after standard treatments will be able to access the CAR-T cell therapy Kymriah.
11th Feb 2019

Two breakthroughs in CAR-T therapy
First child with acute lymphoblastic leukaemia (ALL) receives CAR-T therapy on the NHS and the treatment is made available to adult lymphoma patients.
1st Feb 2019

CAR-T therapies hold promise for cancers
Immunotherapy treatments called CAR-T therapies involve reprogramming a type of ‘supercharged’ immune cell could be mass-produced to help fight cancer.
8th Oct 2018

CAR-T treatment turned down on NHS
The NHS medicines watchdog has recommended that a treatment called Kymriah should not be available to people with diffuse large B-cell lymphoma (DLBCL).
19th Sep 2018
